Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment


#143282

176pages

GBI Research

$ 3500

In Stock


Dermatology Therapeutics Market to 2018 Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment

GBI Research, the leading business intelligence provider, has released its latest research, ""Dermatology Therapeutics Market to 2018 Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment”. The report provides insights into the dermatology therapeutics market including market forecasts up to 2018. It provides an in-depth analysis of the major dermatological indications, which include psoriasis, acne, rosacea, atopic dermatitis, herpes and alopecia, as well as insights into the dermatology therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. The report provides branded and generics segmentation in the therapeutic landscape segment. In addition, it analyzes the dermatology therapeutics market in India, China and Australia. The report discusses the global pipeline for all the dermatological disorders across various stages of development. 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research finds that the dermatology therapeutics market in the top seven markets was valued at $15.8 billion in 2011, increasing at a CAGR of 4.7% during the review period 2004–2011. The market is projected to witness moderate growth of 2.7% during the 2011–2018 forecast period to reach $19.1 billion. The growth is primarily driven by the increase in the psoriasis market, which is attributed to increased competition among the existing products and a strong pipeline with more emerging therapies. In 2011, psoriasis was the largest market segment, accounting for 29.4% of the total dermatology therapeutics market, followed by acne at 20.9%, alopecia at 18.2% and herpes at 16.7%.

Scope

  • Annualized market data for the dermatology therapeutics market from 2004 to 2011, forecast forward to 2018.
  • Analysis of the leading therapeutic segments. These include acne, psoriasis, alopecia, atopic dermatitis, rosacea and herpes.
  • Analysis of the dermatology therapeutics market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
  • Analysis of the dermatology therapeutics market in India, China and Australia.
  • Market characterization of the dermatology therapeutics market including market size, annual cost of treatment, and treatment usage patterns.
  • Key drivers and barriers that have a significant impact on the market.
  • Coverage of pipeline molecules in various phases of drug development.
  • Competitive benchmarking of leading companies. Key companies studied in this report are Johnson & Johnson, Abbott, Amgen, Merck & Co., GlaxoSmithKline and Novartis.
  • Key M&A activities and licensing agreements up to May 2012 in the global dermatology therapeutics market.
  • Information and analysis on aesthetic dermatology.

Reasons to buy

  • Align your product portfolio to the markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the potential region and dermatology therapeutics market segments poised for strong growth.
  • Create a more tailored country strategy through the understanding of key drivers and barriers of the global dermatology abuse therapeutics market.
  • Develop key strategic initiatives by understanding the key focus areas and top selling therapeutics of leading companies.
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Table of Contents

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 10
1.2 List of Figures 12

2 Dermatology Therapeutics Market to 2018 - Introduction 14

3 Dermatology Therapeutics Market to 2018 - Market Overview 15
3.1 Revenue 15
3.2 Annual Cost of Treatment 16
3.3 Treatment Usage Pattern 17
3.3.1 Diseased Population 18
3.3.2 Treatment-Seeking Population 18
3.3.3 Diagnosed Population 18
3.3.4 Prescription Population 18
3.4 Recently Approved Product 18
3.4.1 Fabior (Tazarotene) 18
3.5 Key Trends 19
3.5.1 Potential New Treatment for Skin Diseases 19
3.5.2 Innovative Medicines Initiative Launched in Europe to Address Antibiotic Resistance 19

4 Dermatology Therapeutics Market to 2018 - Geographical Landscape 20
4.1 Revenue by Country 20
4.2 The US 22
4.2.1 Revenue 22
4.2.2 Annual Cost of Treatment 23
4.2.3 Treatment Usage Pattern 24
4.3 Top Five Countries in Europe 25
4.3.1 Revenue 25
4.3.2 Annual Cost of Treatment 28
4.3.3 Treatment Usage Pattern 29
4.4 Japan 31
4.4.1 Revenue 31
4.4.2 Annual Cost of Treatment 32
4.4.3 Treatment Usage Pattern 33

5 Dermatology Therapeutics Market to 2018 - Therapeutic Landscape 35
5.1 Global Alopecia Therapeutics Market 35
5.1.1 Introduction 35
5.1.2 Revenue 36
5.1.3 Annual Cost of Treatment 40
5.1.4 Treatment Usage Pattern 41
5.1.5 Treatment Algorithm 42
5.1.6 Drivers and Restraints 43
5.2 Global Herpes Therapeutics Market 44
5.2.1 Introduction 44
5.2.2 Revenue 47
5.2.3 Annual Cost of Treatment 51
5.2.4 Treatment Usage Pattern 52
5.2.5 Treatment Algorithm 54
5.2.6 Drivers and Restraints 55
5.3 Global Psoriasis Therapeutics Market 56
5.3.1 Introduction 56
5.3.2 Revenue 57
5.3.3 Annual Cost of Treatment 62
5.3.4 Treatment Usage Pattern 63
5.3.5 Treatment Algorithm 65
5.3.6 Drivers and Restraints 66
5.4 Global Acne Therapeutics Market 67
5.4.1 Introduction 67
5.4.2 Revenue 68
5.4.3 Annual Cost of Treatment 72
5.4.4 Treatment Usage Pattern 73
5.4.5 Treatment Algorithm 75
5.4.6 Drivers and Restraints 76
5.5 Global Rosacea Disease Therapeutics Market 77
5.5.1 Introduction 77
5.5.2 Revenue 78
5.5.3 Annual Cost of Treatment 81
5.5.4 Treatment Usage Pattern 82
5.5.5 Treatment Algorithm 84
5.5.6 Drivers and Restraints 85
5.6 Global Atopic Dermatitis Therapeutics Market 86
5.6.1 Introduction 86
5.6.2 Revenue 86
5.6.3 Annual Cost of Treatment 90
5.6.4 Treatment Usage Pattern 91
5.6.5 Treatment Algorithm 93
5.6.6 Drivers and Restraints 94

6 Dermatological Therapeutics Market - Asia-Pacific Countries 96
6.1 India 96
6.1.1 Healthcare Overview 96
6.1.2 Regulatory Landscape 96
6.1.3 Market Overview 98
6.1.4 Key Trends 99
6.1.5 Company Analysis 100
6.1.6 Drivers and Restraints 103
6.2 China 104
6.2.1 Market Overview 104
6.2.2 Key Trends 104
6.3 Australia 105
6.3.1 Market Overview 105
6.3.2 Pricing and Reimbursement 106

7 Dermatological Therapeutics Market to 2018 - Pipeline Analysis 108
7.1 Introduction 108
7.1.1 Research and Development Pipeline - Alopecia 110
7.1.2 Research and Development Pipeline - Herpes 111
7.1.3 Research and Development Pipeline - Psoriasis 112
7.1.4 Research and Development Pipeline - Acne vulgaris 115
7.1.5 Research and Development Pipeline - Rosacea 116
7.1.6 Research and Development Pipeline - Atopic Dermatitis 117
7.2 Key R&D Trends 117
7.3 Promising Molecules - NDA Filed 118
7.3.1 LAS 41002 118
7.3.2 Low-Dose Duac 119
7.3.3 Acnex 120
7.4 Promising Molecules - Phase III 121
7.4.1 Zoster 121
7.4.2 ARYS-01 121
7.4.3 V212 123
7.4.4 CC-10004 124
7.4.5 CD07805/47 125
7.5 Promising Molecules - Phase II 125
7.5.1 EPB-348 125
7.5.2 AMG 827 126
7.5.3 V-101 127
7.5.4 MK-3222 128

8 Dermatology Therapeutics Market to 2018 - Competitive Landscape 129
8.1 Market Share Analysis: Dermatological Disorders 129
8.2 Competitive Profiling 132
8.2.1 Johnson & Johnson 132
8.2.2 Amgen 134
8.2.3 Merck & Co. 136
8.2.4 Abbott Laboratories 137
8.2.5 Pfizer 139
8.2.6 GlaxoSmithKline 141
8.2.7 Novartis 143
8.2.8 Medicis 145
8.2.9 Galderma 147

9 Dermatology Therapeutics Market to 2018 - Deals Analysis 150
9.1 Mergers and Acquisitions 150
9.1.1 Mergers and Acquisitions by Indication 150
9.1.2 Mergers and Acquisitions by Type 152
9.1.3 Mergers and Acquisitions by Value 152
9.1.4 Mergers and Acquisitions by Geography 153
9.1.5 Major Mergers and Acquisitions Deals 154
9.2 Licensing Agreements 155
9.2.1 Licensing Agreements by Indication 155
9.2.2 Licensing Agreements by Year 156
9.2.3 Licensing Agreements by Value 157
9.2.4 Licensing Agreements by Geography 158
9.2.5 Major Licensing Agreements 158

10 Aesthetic Dermatology 160
10.1 Introduction 160
10.2 Drivers and Restraints 162
10.2.1 Drivers 162
10.2.2 Restraints 163
10.3 Botulinum Toxin 163
10.3.1 Major Marketed Products 163
10.3.2 Most Promising Molecules 164
10.4 Dermal Fillers 165
10.4.1 Temporary Biodegradable Fillers 165
10.4.2 Semi-Permanent Biodegradable Fillers 166
10.5 Breast Augmentation 166
10.5.1 Style 410 166
10.5.2 Breast Implants Linked to Lymphoma Risk 166

11 Dermatology Therapeutics Market to 2017 - Appendix 167
11.1 Market Definitions 167
11.2 Abbreviations 167
11.3 Bibliography 169
11.4 Research Methodology 171
11.4.1 Coverage 171
11.4.2 Secondary Research 171
11.4.3 Primary Research 172
11.5 Therapeutic Landscape 172
11.5.2 Market Size by Geography 174
11.6 Geographical Landscape 175
11.7 Pipeline Analysis 175
11.8 Competitive Landscape 175
11.8.1 Expert Panel Validation 175
11.9 Contact Us 175
11.10 Disclaimer 176

Table 1: Dermatology Therapeutics Market, Global, Revenue ($bn), 2004-2011 15
Table 2: Dermatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018 15
Table 3: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 16
Table 4: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 16
Table 5: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 17
Table 6: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018 17
Table 7: Dermatology Therapeutics Market, Revenue by Geography ($bn), 2004-2011 20
Table 8: Dermatology Therapeutics Market, Revenue Forecasts by Geography ($bn), 2011-2018 21
Table 9: Dermatology Therapeutics Market, the US, Revenue ($bn), 2004-2011 22
Table 10: Dermatology Therapeutics Market, The US, Revenue Forecasts ($bn), 2011-2018 22
Table 11: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2004-2011 23
Table 12: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2011-2018 23
Table 13: Dermatology Therapeutics Market, the US, Treatment Usage Pattern (million), 2004-2011 24
Table 14: Dermatology Therapeutics Market, the US, Treatment Usage Pattern (million), 2011-2018 24
Table 15: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue ($m), 2004-2011 26
Table 16: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts ($m), 2011-2018 26
Table 17: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue by Country ($bn), 2004-2011 27
Table 18: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts by Country ($bn), 2011-2018 27
Table 19: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2004-2011 28
Table 20: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2011-2018 28
Table 21: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2004-2011 29
Table 22: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2011-2018 30
Table 23: Dermatology Therapeutics Market, Japan, Revenue ($bn), 2004-2011 31
Table 24: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2011-2018 31
Table 25: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2004-2011 32
Table 26: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2011-2018 32
Table 27: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2004-2011 33
Table 28: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2011-2018 33
Table 29: Alopecia Therapeutics Market, Global, Revenue ($bn), 2004-2011 37
Table 30: Alopecia Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018 37
Table 31: Alopecia Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011 38
Table 32: Alopecia Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018 39
Table 33: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 40
Table 34: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 40
Table 35: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 41
Table 36: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018 41
Table 37: Herpes Therapeutics Market, Global, Revenue ($bn), 2004-2011 47
Table 38: Herpes Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018 47
Table 39: Herpes Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011 49
Table 40: Herpes Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018 49
Table 41: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 51
Table 42: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 51
Table 43: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 52
Table 44: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018 52
Table 45: Psoriasis Therapeutics Market, Global, Revenues ($bn), 2004-2011 57
Table 46: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018 58
Table 47: Psoriasis Therapeutics Market, Global, Marketed Products, 2012 58
Table 48: Psoriasis Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011 60
Table 49: Psoriasis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018 60
Table 50: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 62
Table 51: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 62
Table 52: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 64
Table 53: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 64
Table 54: Acne Therapeutics Market, Global, Revenue ($bn), 2004-2011 68
Table 55: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018 68
Table 56: Acne Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011 70
Table 57: Acne Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018 71
Table 58: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 72
Table 59: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 72
Table 60: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 73
Table 61: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018 74
Table 62: Rosacea Therapeutics Market, Global, Revenue ($bn), 2004-2011 78
Table 63: Rosacea Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018 78
Table 64: Rosacea Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011 79
Table 65: Rosacea Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018 80
Table 66: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 81
Table 67: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 81
Table 68: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 82
Table 69: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018 83
Table 70: Atopic Dermatitis Therapeutics Market, Global, Revenue ($m), 2004-2011 87
Table 71: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2011-2018 87
Table 72: Atopic Dermatitis Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011 88
Table 73: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018 89
Table 74: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011 90
Table 75: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018 90
Table 76: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011 91
Table 77: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018 92
Table 78: Dermatology Therapeutics Market to 2018, NLEM, Dermatological Medicines Topical, India, 2011 98
Table 79: Dermatology Therapeutics Market to 2018, Marketed Products, Glenmark, India, 2012 101
Table 80: Dermatology Therapeutics Market to 2018, Marketed Products, Galderma, India, 2012 102
Table 81: Dermatology Therapeutics Market to 2018, Major Marketed Products, Australia, 2012 105
Table 82: Dermatology Therapeutics Market to 2018, PBS Reimbursement List, Australia, 2012 106
Table 83: Dermatology Therapeutics Market, Global, Other Manufacturers, 2011 129
Figure 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018 15
Figure 2: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 16
Figure 3: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 17
Figure 4: Dermatology Therapeutics Market, Revenue Forecasts by Geography ($bn), 2004-2018 20
Figure 5: Dermatology Therapeutics Market, the US, Revenue Forecasts ($bn), 2004-2018 22
Figure 6: Dermatology Therapeutics Market, the US, Annual Cost of Treatment ($), 2004-2018 23
Figure 7: Dermatology Therapeutics Market, the US, Treatment Usage Pattern (million), 2004-2018 24
Figure 8: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts ($bn), 2004-2018 25
Figure 9: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts by Country ($bn), 2004-2018 26
Figure 10: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2004-2018 28
Figure 11: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2004-2018 29
Figure 12: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2004-2018 31
Figure 13: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2004-2018 32
Figure 14: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2004-2018 33
Figure 15: Alopecia Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018 36
Figure 16: Alopecia Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018 38
Figure 17: Alopecia Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018 39
Figure 18: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 40
Figure 19: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 41
Figure 20: Alopecia Therapeutics Market, Global, Treatment Algorithm 42
Figure 21: Alopecia Therapeutics Market, Drivers and Restraints, 2012 43
Figure 22: Herpes Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018 47
Figure 23: Herpes Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018 48
Figure 24: Herpes Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018 50
Figure 25: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 51
Figure 26: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 52
Figure 27: Herpes Therapeutics Market, Global, Treatment Algorithm 54
Figure 28: Herpes Therapeutics Market, Drivers and Restraints, 2012 55
Figure 29: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018 57
Figure 30: Psoriasis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018 59
Figure 31: Psoriasis Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018 61
Figure 32: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 62
Figure 33: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 63
Figure 34: Psoriasis Therapeutics Market, Global, Treatment Algorithm 65
Figure 35: Psoriasis Therapeutics Market, Drivers and Restraints, 2012 66
Figure 36: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018 68
Figure 37: Acne Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018 70
Figure 38: Acne Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018 71
Figure 39: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 72
Figure 40: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 73
Figure 41: Acne Therapeutics Market, Global, Treatment Algorithm 75
Figure 42: Acne Therapeutics Market, Drivers and Restraints, 2012 76
Figure 43: Rosacea Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018 78
Figure 44: Rosacea Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018 79
Figure 45: Rosacea Therapeutics Market, Global, Revenue Segmentation (%), 2010 and 2017 80
Figure 46: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 81
Figure 47: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 82
Figure 48: Rosacea Therapeutics Market, Global, Treatment Algorithm 84
Figure 49: Rosacea Therapeutics Market, Drivers and Restraints, 2012 85
Figure 50: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2004-2018 86
Figure 51: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018 88
Figure 52: Atopic Dermatitis Therapeutics Market, Global, Revenue Segmentation (%), 2010 and 2017 89
Figure 53: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018 90
Figure 54: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018 91
Figure 55: Atopic Dermatitis Therapeutics Market, Global, Treatment Algorithm 93
Figure 56: Atopic Dermatitis Therapeutics Market, Drivers and Barriers, 2012 94
Figure 57: Dermatology Therapeutics Market to 2018, Drivers and Restraints, India, 2012 103
Figure 58: Dermatology Therapeutics Market, R&D Pipeline by Indication (%), 2012 108
Figure 59: Dermatology Therapeutics Market, Global, R&D Pipeline by Phase (%), 2012 109
Figure 60: Dermatology Therapeutics Market, Alopecia, R&D Pipeline by Phase (%), 2012 110
Figure 61: Dermatology Therapeutics Market, Herpes, R&D Pipeline by Phase (%), 2012 111
Figure 62: Dermatology Therapeutics Market, Psoriasis, R&D Pipeline by Phase (%), 2012 112
Figure 63: Dermatology Therapeutics Market, Acne Vulgaris, R&D Pipeline by Phase (%), 2012 115
Figure 64: Dermatology Therapeutics Market, Rosacea, R&D Pipeline by Phase (%), 2012 116
Figure 65: Dermatology Therapeutics Market, Atopic Dermatitis, R&D Pipeline by Phase (%), 2012 117
Figure 66: Dermatology Therapeutics Market, Global, Market Share of Top Manufacturers, 2011 129
Figure 67: Dermatology Therapeutics Market, Global, SWOT Analysis, Johnson & Johnson, 2012 134
Figure 68: Dermatology Therapeutics Market, Global, SWOT Analysis, Amgen, 2012 135
Figure 69: Dermatology Therapeutics Market, Global, SWOT Analysis, Merck, 2012 137
Figure 70: Dermatology Therapeutics Market, Global, SWOT Analysis, Abbott Laboratories, 2012 139
Figure 71: Dermatology Therapeutics Market, Global, SWOT Analysis, Pfizer, 2012 141
Figure 72: Dermatology Therapeutics Market, Global, SWOT Analysis, GlaxoSmithKline, 2012 143
Figure 73: Dermatology Therapeutics Market, Global, SWOT Analysis, Novartis AG, 2012 145
Figure 74: Dermatology Therapeutics Market, Global, SWOT Analysis, Medicis, 2012 146
Figure 75: Dermatology Therapeutics Market, Global, SWOT Analysis, Galderma, 2012 149
Figure 76: Dermatological Disorders Therapeutics Market, Global, Mergers and Acquisitions by Indication (%), 2009-2012 150
Figure 77: Dermatological Disorders Therapeutics Market, Mergers and Acquisitions by Year, 2009-2012 151
Figure 78: Dermatological Disorders Therapeutics Market, Mergers and Acquisitions by Type (%), 2009-2012 152
Figure 79: Dermatological Disorders Therapeutics Market, Mergers and Acquisitions by Value (%), 2009-2012 152
Figure 80: Dermatology Therapeutics Market, Mergers and Acquisitions by Geography (%), 2009-2012 153
Figure 81: Dermatology Therapeutics Market, Global, Licensing Agreements by Indication, 2009-2012 155
Figure 82: Dermatology Therapeutics Market, Global, Licensing Agreements by Year, 2009-2012 156
Figure 83: Dermatological Disorders Therapeutics Market, Global, Licensing Agreements by Value (%), 2009-2012 157
Figure 84: Dermatological Therapeutics Market, Global, Licensing Agreements by Geography, 2009-2012 158
Figure 85: Aesthetic Dermatology, Cosmetic and Reconstructive Plastic Surgery Trends, the US, 2011 160
Figure 86: Aesthetic Dermatology, Cosmetic Plastic Surgery Demographic Trends, the US, 2011 161
Figure 87: Aesthetic Dermatology, Drivers and Restraints, 2012 162
Figure 88: GBI Research Market Forecasting Model 174